首页> 中文期刊> 《中国全科医学》 >美国《2017年成人高血压预防、诊断、评估和管理指南》解读与评析

美国《2017年成人高血压预防、诊断、评估和管理指南》解读与评析

摘要

After its publication in 2013,evidence-based guideline for the management of high blood pressure in adults report from the panel members of appointed to the Eighth Joint National Committee (JNC8) has caused widespread controversy in the world.Four years later,some academic institutions,such as the American College of Cardiology(ACC) and the American Heart Association(AHA),organized experts to write a new version of hypertension guidelines.Many recommendations of the new guidelines were impacted significantly by the results of SPRINT trail,and made more radical recommendations for the diagnosis of hypertension and the targets of blood pressure control.Because of the different national conditions,some of the guidelines may not apply to China.The clinical practice in China should still be based on the current Chinese guidelines for the prevention and treatment of hypertension.%2013年美国国家联合委员会第8版高血压指南(JNC8)颁布后,在国际上引起广泛争议.时隔4年,美国心脏病学会(ACC)、美国心脏协会(AHA)等学术机构再次组织专家撰写了新版高血压指南.新指南的诸多推荐建议受到了SPRINT研究结果的显著影响,对高血压的诊断以及血压控制目标提出了更为激进的建议.由于国情不同,该指南的部分推荐可能并不适用于我国,我国的临床实践仍应以我国现行的高血压防治指南为依据.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号